drugset / Press release
Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data
2020-12-28 · Arcturus Therapeutics, Inc. · original arcturusrx.com ↗
PDF Version 273.2 KB
The release as fetched from its publisher. arcturusrx.com ↗